137 related articles for article (PubMed ID: 7273597)
1. Clonazepam acetylation in fast and slow acetylators.
Miller ME; Garland WA; Min BH; Ludwick BT; Ballard RH; Levy RH
Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the metabolism of procainamide and sulfamethazine.
Giardina E-GV ; Stein RM; Bigger JT
Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic acetylation of 7-amino-clonazepam in human liver cytosol.
Peng DR; Birgersson C; von Bahr C; Rane A
Pediatr Pharmacol (New York); 1984; 4(3):155-9. PubMed ID: 6493838
[TBL] [Abstract][Full Text] [Related]
4. N-acetylation phenotyping with sulphadimidine in a Turkish population.
Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
[TBL] [Abstract][Full Text] [Related]
5. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
Hombhanje F
Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
Hall S
Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
Peters JH; Gordon GR; Karat AB
Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
[TBL] [Abstract][Full Text] [Related]
8. Polymorphically acetylated aminoglutethimide in humans.
Coombes RC; Foster AB; Harland SJ; Jarman M; Nice EC
Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
[TBL] [Abstract][Full Text] [Related]
9. Screening methods using sulfamethazine for determining acetylator phenotype.
du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
Olson W; Miceli J; Weber W
Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
[TBL] [Abstract][Full Text] [Related]
11. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
12. N-acetylation in healthy and diseased children.
Hadasová E; Brysová V; Kadlcáková E
Eur J Clin Pharmacol; 1990; 39(1):43-7. PubMed ID: 2276387
[TBL] [Abstract][Full Text] [Related]
13. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
Zysset T; Peretti E
Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
[TBL] [Abstract][Full Text] [Related]
14. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M
Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
[TBL] [Abstract][Full Text] [Related]
15. N-acetylation phenotyping with sulfamethazine in an Iranian population.
Sardaş S; Lahijany B; Cok I; Karakaya AE
Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
[TBL] [Abstract][Full Text] [Related]
16. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
17. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
Chapron DJ; Kramer PA; Mercik SA
Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of biotransformation of clonazepam to its 7-amino metabolite in the monkey.
Lai AA; Min BH; Garland WA; Levy RH
J Pharmacokinet Biopharm; 1979 Feb; 7(1):87-95. PubMed ID: 110917
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the acetylation of procainamide and sulfadimidine in man.
Frislid K; Berg M; Hansteen V; Lunde PK
Eur J Clin Pharmacol; 1976 Mar; 09(5-6):433-8. PubMed ID: 971707
[TBL] [Abstract][Full Text] [Related]
20. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
Hadasová E; Brysová V; Utĕsený J; Macků M
Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
